EUIPO The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.
Protect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark XABEMELI was filed as Word mark on 03/27/2015 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/06/2015.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 013884622 |
| Application date | March 27, 2015 |
| Publication date | June 29, 2015 |
| Entry date | October 6, 2015 |
| Expiration date | March 27, 2025 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations namely, pharmaceutical preparations for the diagnosis, prevention and/or treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and/or treatment of blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia; pharmaceutical preparations for the diagnosis, prevention and/or treatment of endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and/or treatment of migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders; pharmaceutical preparations for the diagnosis, prevention and/or treatment of reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants; diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 5, 2019 | Change Representative, Published | ||
| December 20, 2018 | Change Representative, Published |
ID: 11013884622